138 related articles for article (PubMed ID: 19603503)
1. Crystal polymorphism in a carbamazepine derivative: oxcarbazepine.
Lutker KM; Matzger AJ
J Pharm Sci; 2010 Feb; 99(2):794-803. PubMed ID: 19603503
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I.
Grzesiak AL; Lang M; Kim K; Matzger AJ
J Pharm Sci; 2003 Nov; 92(11):2260-71. PubMed ID: 14603511
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine.
Lowes MM; Caira MR; Lötter AP; Van der Watt JG
J Pharm Sci; 1987 Sep; 76(9):744-52. PubMed ID: 11002813
[TBL] [Abstract][Full Text] [Related]
4. Crystallization of carbamazepine pseudopolymorphs from nonionic microemulsions.
Kogan A; Popov I; Uvarov V; Cohen S; Aserin A; Garti N
Langmuir; 2008 Feb; 24(3):722-33. PubMed ID: 18163657
[TBL] [Abstract][Full Text] [Related]
5. Solid-state study of polymorphic drugs: carbamazepine.
Rustichelli C; Gamberini G; Ferioli V; Gamberini MC; Ficarra R; Tommasini S
J Pharm Biomed Anal; 2000 Aug; 23(1):41-54. PubMed ID: 10898153
[TBL] [Abstract][Full Text] [Related]
6. Spray Drying as a Reliable Route to Produce Metastable Carbamazepine Form IV.
Halliwell RA; Bhardwaj RM; Brown CJ; Briggs NEB; Dunn J; Robertson J; Nordon A; Florence AJ
J Pharm Sci; 2017 Jul; 106(7):1874-1880. PubMed ID: 28431966
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamic Investigation of Carbamazepine-Saccharin Co-Crystal Polymorphs.
Pagire SK; Jadav N; Vangala VR; Whiteside B; Paradkar A
J Pharm Sci; 2017 Aug; 106(8):2009-2014. PubMed ID: 28435141
[TBL] [Abstract][Full Text] [Related]
8. Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS).
Edwards AD; Shekunov BY; Kordikowski A; Forbes RT; York P
J Pharm Sci; 2001 Aug; 90(8):1115-24. PubMed ID: 11536216
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine/betaCD/HPMC solid dispersions. II. Physical characterization.
Koester LS; Mayorga P; Pereira VP; Petzhold CL; Bassani VL
Drug Dev Ind Pharm; 2003 Feb; 29(2):145-54. PubMed ID: 12648011
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine polymorphism: A re-visitation using Raman imaging.
Fateixa S; Nogueira HIS; Trindade T
Int J Pharm; 2022 Apr; 617():121632. PubMed ID: 35245634
[TBL] [Abstract][Full Text] [Related]
11. Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy.
Tian F; Zeitler JA; Strachan CJ; Saville DJ; Gordon KC; Rades T
J Pharm Biomed Anal; 2006 Feb; 40(2):271-80. PubMed ID: 16146681
[TBL] [Abstract][Full Text] [Related]
12. Performance comparison of a co-crystal of carbamazepine with marketed product.
Hickey MB; Peterson ML; Scoppettuolo LA; Morrisette SL; Vetter A; Guzmán H; Remenar JF; Zhang Z; Tawa MD; Haley S; Zaworotko MJ; Almarsson O
Eur J Pharm Biopharm; 2007 Aug; 67(1):112-9. PubMed ID: 17292592
[TBL] [Abstract][Full Text] [Related]
13. Visualizing the conversion of carbamazepine in aqueous suspension with and without the presence of excipients: a single crystal study using SEM and Raman microscopy.
Tian F; Sandler N; Gordon KC; McGoverin CM; Reay A; Strachan CJ; Saville DJ; Rades T
Eur J Pharm Biopharm; 2006 Nov; 64(3):326-35. PubMed ID: 16846721
[TBL] [Abstract][Full Text] [Related]
14. Time-resolved X-ray scattering using synchrotron radiation applied to the study of a polymorphic transition in carbamazepine.
Edwards AD; Shekunov BY; Forbes RT; Grossmann JG; York P
J Pharm Sci; 2001 Aug; 90(8):1106-14. PubMed ID: 11536215
[TBL] [Abstract][Full Text] [Related]
15. Investigation of intrinsic dissolution behavior of different carbamazepine samples.
Sehić S; Betz G; Hadzidedić S; El-Arini SK; Leuenberger H
Int J Pharm; 2010 Feb; 386(1-2):77-90. PubMed ID: 19900519
[TBL] [Abstract][Full Text] [Related]
16. Variability in commercial carbamazepine samples--impact on drug release.
Flicker F; Eberle VA; Betz G
Int J Pharm; 2011 May; 410(1-2):99-106. PubMed ID: 21435386
[TBL] [Abstract][Full Text] [Related]
17. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization of solid dispersions of three antiepileptic drugs prepared by solvent evaporation method.
Douroumis D; Bouropoulos N; Fahr A
J Pharm Pharmacol; 2007 May; 59(5):645-53. PubMed ID: 17524229
[TBL] [Abstract][Full Text] [Related]
19. The effect of egg albumin on the crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets and in aqueous solutions.
Katzhendler I; Azoury R; Friedman M
J Control Release; 2000 Apr; 65(3):331-43. PubMed ID: 10699292
[TBL] [Abstract][Full Text] [Related]
20. Quantitative phase analyses through the Rietveld method with X-ray powder diffraction data of heat-treated carbamazepine form III.
Antonio SG; Benini FR; Ferreira FF; Rosa PC; Paiva-santos Cde O
J Pharm Sci; 2011 Jul; 100(7):2658-64. PubMed ID: 21259240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
